These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 15378768)
1. Alteration of cyclin D1 in gastric carcinoma and its clinicopathologic significance. Gao P; Zhou GY; Liu Y; Li JS; Zhen JH; Yuan YP World J Gastroenterol; 2004 Oct; 10(20):2936-9. PubMed ID: 15378768 [TBL] [Abstract][Full Text] [Related]
2. Correlation of RKIP, STAT3 and cyclin D1 expression in pathogenesis of gastric cancer. Zhang XM; Zhou C; Gu H; Yan L; Zhang GY Int J Clin Exp Pathol; 2014; 7(9):5902-8. PubMed ID: 25337233 [TBL] [Abstract][Full Text] [Related]
3. Alteration of cyclin D1 in Chinese patients with breast carcinoma and its correlation with Ki-67, pRb, and p53. Guo LL; Gao P; Wu YG; Jian WC; Hao CY; Li H; Lin XY Arch Med Res; 2007 Nov; 38(8):846-52. PubMed ID: 17923265 [TBL] [Abstract][Full Text] [Related]
4. Cyclin D1 and cyclin E2 are differentially expressed in gastric cancer. Kumari S; Puneet ; Prasad SB; Yadav SS; Kumar M; Khanna A; Dixit VK; Nath G; Singh S; Narayan G Med Oncol; 2016 May; 33(5):40. PubMed ID: 27034264 [TBL] [Abstract][Full Text] [Related]
5. Expression of retinoblastoma and cyclin D1 in gastric carcinoma. Arici DS; Tuncer E; Ozer H; Simek G; Koyuncu A Neoplasma; 2009; 56(1):63-7. PubMed ID: 19152247 [TBL] [Abstract][Full Text] [Related]
6. [Expression and significance of cell cycle regulators in gastric carcinoma]. Wu JF; Shao JC; Wang DB; Qin R; Zhang H Ai Zheng; 2005 Feb; 24(2):175-9. PubMed ID: 15694028 [TBL] [Abstract][Full Text] [Related]
7. Abnormal expression of p16(INK4a), cyclin D1, cyclin-dependent kinase 4 and retinoblastoma protein in gastric carcinomas. Kishimoto I; Mitomi H; Ohkura Y; Kanazawa H; Fukui N; Watanabe M J Surg Oncol; 2008 Jul; 98(1):60-6. PubMed ID: 18484097 [TBL] [Abstract][Full Text] [Related]
8. Frequent amplification of the cyclin E gene in human gastric carcinomas. Akama Y; Yasui W; Yokozaki H; Kuniyasu H; Kitahara K; Ishikawa T; Tahara E Jpn J Cancer Res; 1995 Jul; 86(7):617-21. PubMed ID: 7559076 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of cyclin D1 mRNA expression in gastric and colorectal cancers. Oda K; Okabayashi T; Kataoka M; Takeda A; Shibuya Y; Orita K; Tanaka N Res Commun Mol Pathol Pharmacol; 1999; 105(3):237-52. PubMed ID: 10954128 [TBL] [Abstract][Full Text] [Related]
10. Expression and significance of Wnt signaling components and their target genes in breast carcinoma. He Y; Liu Z; Qiao C; Xu M; Yu J; Li G Mol Med Rep; 2014 Jan; 9(1):137-43. PubMed ID: 24190141 [TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical study on the expression of cyclin D1 and E in gastric cancer. Aoyagi K; Koufuji K; Yano S; Murakami N; Terasaki Y; Yamasaki Y; Takeda J; Tanaka M; Shirouzu K Kurume Med J; 2000; 47(3):199-203. PubMed ID: 11059220 [TBL] [Abstract][Full Text] [Related]
12. Cyclin D1 antisense oligodexoyneucleotides inhibits growth and enhances chemosensitivity in gastric carcinoma cells. Shuai XM; Han GX; Wang GB; Chen JH World J Gastroenterol; 2006 Mar; 12(11):1766-9. PubMed ID: 16586549 [TBL] [Abstract][Full Text] [Related]
13. Lack of cyclin D1 overexpression in gastric carcinogenesis. Blok P; Craanen ME; van Diest PJ; Dekker W; Tytgat GN Histopathology; 2000 Feb; 36(2):151-5. PubMed ID: 10672060 [TBL] [Abstract][Full Text] [Related]
14. High-level expression of S100A4 correlates with lymph node metastasis and poor prognosis in patients with gastric cancer. Wang YY; Ye ZY; Zhao ZS; Tao HQ; Chu YQ Ann Surg Oncol; 2010 Jan; 17(1):89-97. PubMed ID: 19820999 [TBL] [Abstract][Full Text] [Related]
15. Reduced expression of cyclin-dependent kinase inhibitor p27Kip1 is associated with advanced stage and invasiveness of gastric carcinomas. Yasui W; Kudo Y; Semba S; Yokozaki H; Tahara E Jpn J Cancer Res; 1997 Jul; 88(7):625-9. PubMed ID: 9310133 [TBL] [Abstract][Full Text] [Related]
16. Overexpression of cyclin D1 occurs in both squamous carcinomas and adenocarcinomas of the esophagus and in adenocarcinomas of the stomach. Arber N; Gammon MD; Hibshoosh H; Britton JA; Zhang Y; Schonberg JB; Roterdam H; Fabian I; Holt PR; Weinstein IB Hum Pathol; 1999 Sep; 30(9):1087-92. PubMed ID: 10492044 [TBL] [Abstract][Full Text] [Related]
17. HIF2α is associated with poor prognosis and affects the expression levels of survivin and cyclin D1 in gastric carcinoma. Tong WW; Tong GH; Chen XX; Zheng HC; Wang YZ Int J Oncol; 2015 Jan; 46(1):233-42. PubMed ID: 25338835 [TBL] [Abstract][Full Text] [Related]
18. Expression of E-cadherin, beta-catenin, CD44s and CD44v6 in gastric adenocarcinoma: relationship with lymph node metastasis. Joo M; Lee HK; Kang YK Anticancer Res; 2003; 23(2B):1581-8. PubMed ID: 12820426 [TBL] [Abstract][Full Text] [Related]
19. Nuclear or cytoplasmic localization of Bag-1 distinctly correlates with pathologic behavior and outcome of gastric carcinomas. Zheng HC; Xu XY; Xing YN; Wei ZL; Takahashi H; Masuda S; Takano Y Hum Pathol; 2010 May; 41(5):724-36. PubMed ID: 20096920 [TBL] [Abstract][Full Text] [Related]
20. Prognostic Value of Cyclin D1 and CD44 Expression in Gastric Adenocarcinoma. Ibrahim HM; AbdElbary AM; Mohamed SY; Elwan A; Abdelhamid MI; Ibrahim A J Gastrointest Cancer; 2019 Sep; 50(3):370-379. PubMed ID: 29497929 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]